The prevalence of hereditary cancers attributed to pathogenic variants in the BRCA1 and BRCA2 genes in unselected BC patients from Latin America and the Caribbean varies from 1.2% in Columbia to 27.1% in the Bahamas [12]. This evidence concerns the gene BRCA2 and breast cancer.